What is Scilligence?
Scilligence operates at the intersection of advanced informatics and scientific research, providing a comprehensive ecosystem designed to streamline R&D workflows. The company's core product suite, which includes an Electronic Lab Notebook, Registration and Assay Database, and sophisticated Materials Inventory systems, serves as a digital backbone for organizations in the chemical and academic sectors. By integrating artificial intelligence and machine learning into its data capture and reporting frameworks, Scilligence enables research teams to accelerate the pace of discovery. The firm distinguishes itself by maintaining a scientist-led approach, ensuring that its technological solutions are not only technically sound but also deeply aligned with the practical, high-stakes requirements of modern laboratory environments.
How much funding has Scilligence raised?
Scilligence has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Scilligence
PPP
Public-Private Partnership
What's next for Scilligence?
With the successful closure of this late-stage financing, Scilligence is poised to accelerate its product roadmap and expand its footprint within the global life sciences market. The strategic focus will likely shift toward enhancing the interoperability of its existing platforms and scaling its AI-driven analytics capabilities to provide deeper insights into complex research datasets. As the company continues to align its business objectives with the needs of large-scale research organizations, the focus will remain on maintaining its competitive edge through innovation and personalized scientific support. This capital deployment will be instrumental in fostering long-term growth and solidifying the company's role as a critical infrastructure provider for the next generation of scientific discovery.
See full Scilligence company page
